New study shows Striking Benefits Found in Ultra-Low Cholesterol

[Guest guest]

http://www.nytimes.com/2004/03/09/health/09STAT.html?pagewanted=1 & th

http://www.washingtonpost.com/wp-dyn/articles/A40105-2004Mar8.html

In part the articles say:

" The study compared high doses of one of the most powerful

cholesterol-lowering drugs, Lipitor, made by Pfizer Inc., with a less

potent drug, Pravachol, made by Bristol-Myers Squibb, which sponsored

the trial. The patients taking Lipitor were significantly less likely

to have heart attacks or to require bypass surgery or angioplasty, the

study found. "

So now, when you go to the doctor he is most certainly going to demand

that you to take one of these classes of drugs.

" The findings should prompt doctors to give much higher doses of drugs

known as statins to hundreds of thousands of patients who already have

severe heart problems, experts said. In addition, it will probably

encourage physicians to start giving the medications to millions of

healthy people who are not yet on them, and to boost dosages for some

of those already taking them to lower their cholesterol even more,

they said. "

All in the name of profit.

Sharon